Dr. Jane Show Wada, MD

Dr. Wada practices at Verdugo Dermatology in Glendale, California.

Dr. Wada's NPI, 1609862242, was assigned on September 20, 2005. Dr. Wada graduated from Keck School of Medicine of USC in 1974. Dr. Wada holds California license G30116.

Dr. Wada's primary practice is Verdugo Dermatology, at 3600 N Verdugo Rd Suite 210 Suite 210, Glendale, CA 91208-1258. The practice phone is (818) 658-2300.

Dr. Wada's primary practice is Verdugo Dermatology in Glendale, California. The medical group on file is Verdugo Dermatology. Dmand AI also links Dr. Wada to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wada practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Wada's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Wada is board certified in dermatology by the American Board of Dermatology. Dr. Wada is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives and itchy rashes among the conditions Dr. Wada treats.

CMS data shows 1,986 Medicare services from Dr. Wada across 16 procedure codes in 2024, for 336 Medicare patients. Medicare paid $128,755 for them. Every service was in an office.

CMS counts 336 Medicare patients who saw Dr. Wada in 2024. The largest group is 75 to 84, with 140 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wada's median patient age at 74, with 59% women.

In 2024, Dr. Wada wrote 447 Medicare Part D claims for 131 patients. 89% of them were for generic drugs. CMS names the drug for 248 of them, across 10 drugs with 11 or more claims each, at $27,130 in total drug cost. In 2023, CMS named 313 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Wada for performance year 2024, reported as part of a group. Dr. Wada accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 712 procedures of removal of skin lesions by Dr. Wada, more than 90% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 410 general payments to Dr. Wada from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $1,229.

Dmand AI lists 4 awards for Dr. Wada, most recently Top Doctors:LA Area in 2013.

Dr. Wada graduated from Keck School of Medicine of USC in 1974. Dr. Wada is a member of AAD and ASDS.

Dr. Wada is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.